Unlock stock picks and a broker-level newsfeed that powers Wall Street.
36.35
-2.72
(-6.96%)
At close: 4:00:00 PM EDT
36.35
0.00
(0.00%)
After hours: 4:05:13 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 7 | 8 |
| Avg. Estimate | -0.77 | -0.8 | -3.15 | -3.61 |
| Low Estimate | -0.82 | -0.86 | -3.33 | -4.31 |
| High Estimate | -0.73 | -0.73 | -2.84 | -1.83 |
| Year Ago EPS | -0.22 | -0.39 | -1.89 | -3.15 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 14 | 12 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.21 | -0.28 | -0.45 | -0.59 |
| EPS Actual | -0.22 | -0.39 | -0.56 | -0.72 |
| Difference | -0.01 | -0.11 | -0.11 | -0.13 |
| Surprise % | -7.12% | -37.71% | -23.33% | -21.46% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.77 | -0.8 | -3.15 | -3.61 |
| 7 Days Ago | -0.76 | -0.8 | -3.14 | -3.61 |
| 30 Days Ago | -0.63 | -0.69 | -2.53 | -3.3 |
| 60 Days Ago | -0.63 | -0.69 | -2.51 | -3.34 |
| 90 Days Ago | -0.62 | -0.68 | -2.54 | -3.34 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | 2 | 2 | 3 | 1 |
| Down Last 30 Days | 2 | 2 | 4 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MLTX | -248.49% | -104.70% | -66.41% | -14.81% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Initiated | RBC Capital: Outperform | 3/18/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 2/27/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/27/2025 |
| Maintains | Needham: Buy to Buy | 2/27/2025 |
| Upgrade | Goldman Sachs: Neutral to Buy | 1/17/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/10/2025 |
Related Tickers
VRDN Viridian Therapeutics, Inc.
12.56
-6.82%
SRRK Scholar Rock Holding Corporation
30.06
-6.50%
ACLX Arcellx, Inc.
60.70
-7.47%
MRUS Merus N.V.
39.60
-5.92%
NAMS NewAmsterdam Pharma Company N.V.
18.38
-10.21%
CRNX Crinetics Pharmaceuticals, Inc.
30.62
-8.71%
EWTX Edgewise Therapeutics, Inc.
20.13
-8.50%
JANX Janux Therapeutics, Inc.
26.81
-0.70%
APGE Apogee Therapeutics, Inc.
35.61
-4.68%
AKRO Akero Therapeutics, Inc.
38.64
-4.55%